Atlas Trials

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Clinical trial NCT00311311 · TERMINATED

Trial details

NCT number
NCT00311311
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
AtherosclerosisKidney Failure
Start date
2006-04-01
Primary completion
2010-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.